Echocardiographic evaluation of cardiac recovery after refractory out-of-hospital cardiac arrest.


Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
09 2020
Historique:
received: 05 04 2020
revised: 17 06 2020
accepted: 23 06 2020
pubmed: 17 7 2020
medline: 22 6 2021
entrez: 17 7 2020
Statut: ppublish

Résumé

The mechanisms and degree of myocardial recovery during treatment with venoarterial extracorporeal membrane oxygenation (VA-ECMO) are unclear. We performed a descriptive study to evaluate myocardial recovery and changes in parameters of myocardial loading using echocardiography. We retrospectively evaluated patients with refractory ventricular tachycardia/ventricular fibrillation out-of-hospital cardiac arrest who were treated with the Minnesota Resuscitation Consortium protocol. Left ventricular ejection fraction (LVEF), end-diastolic diameter (LVEDD), end-systolic diameter (LVESD), and fractional shortening were assessed using serial echocardiography. One-way analysis of variance (ANOVA) was used to compare parameters over six hospitalization stages. Two-way ANOVA was used to compare these parameters between patients that survived the index hospitalization and those that died. 77 patients had >1 echocardiographic turndown evaluations. Thirty-eight patients survived to discharge and 39 patients died. Of 39 in-hospital deaths, 17 patients died before VA-ECMO decannulation and 22 patients died after VA-ECMO decannulation. Among all patients, LVEF improved from 9.7 ± 10.1% from the first echocardiogram after rewarming to 43.1 ± 13.1% after decannulation (p < 0.001) and fractional shortening ratio improved from 0.14 ± 0.12 to 0.31 ± 0.14 (p < 0.001). The LVEDD and LVESD remained stable (p = 0.36 and p = 0.12, respectively). Patients that died had a lower LVEF by an average of 6.93% (95% confidence interval: -10.0 to -3.83, p < 0.001), but other parameters were similar. Refractory cardiac arrest patients treated with VA-ECMO experience significant recovery of ventricular function during treatment. We postulate that this primarily occurs via reduction of LV preload.

Sections du résumé

BACKGROUND
The mechanisms and degree of myocardial recovery during treatment with venoarterial extracorporeal membrane oxygenation (VA-ECMO) are unclear. We performed a descriptive study to evaluate myocardial recovery and changes in parameters of myocardial loading using echocardiography.
METHODS
We retrospectively evaluated patients with refractory ventricular tachycardia/ventricular fibrillation out-of-hospital cardiac arrest who were treated with the Minnesota Resuscitation Consortium protocol. Left ventricular ejection fraction (LVEF), end-diastolic diameter (LVEDD), end-systolic diameter (LVESD), and fractional shortening were assessed using serial echocardiography. One-way analysis of variance (ANOVA) was used to compare parameters over six hospitalization stages. Two-way ANOVA was used to compare these parameters between patients that survived the index hospitalization and those that died.
RESULTS
77 patients had >1 echocardiographic turndown evaluations. Thirty-eight patients survived to discharge and 39 patients died. Of 39 in-hospital deaths, 17 patients died before VA-ECMO decannulation and 22 patients died after VA-ECMO decannulation. Among all patients, LVEF improved from 9.7 ± 10.1% from the first echocardiogram after rewarming to 43.1 ± 13.1% after decannulation (p < 0.001) and fractional shortening ratio improved from 0.14 ± 0.12 to 0.31 ± 0.14 (p < 0.001). The LVEDD and LVESD remained stable (p = 0.36 and p = 0.12, respectively). Patients that died had a lower LVEF by an average of 6.93% (95% confidence interval: -10.0 to -3.83, p < 0.001), but other parameters were similar.
CONCLUSION
Refractory cardiac arrest patients treated with VA-ECMO experience significant recovery of ventricular function during treatment. We postulate that this primarily occurs via reduction of LV preload.

Identifiants

pubmed: 32673734
pii: S0300-9572(20)30276-8
doi: 10.1016/j.resuscitation.2020.06.037
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-46

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Rajat Kalra (R)

Cardiovascular Division, University of Minnesota, Minneapolis, MN, United States; Center for Resuscitation Medicine, University of Minnesota, Minneapolis, MN, USA.

Jason A Bartos (JA)

Cardiovascular Division, University of Minnesota, Minneapolis, MN, United States; Center for Resuscitation Medicine, University of Minnesota, Minneapolis, MN, USA.

Marinos Kosmopoulos (M)

Cardiovascular Division, University of Minnesota, Minneapolis, MN, United States; Center for Resuscitation Medicine, University of Minnesota, Minneapolis, MN, USA.

Claire Carlson (C)

Cardiovascular Division, University of Minnesota, Minneapolis, MN, United States; Center for Resuscitation Medicine, University of Minnesota, Minneapolis, MN, USA.

Ranjit John (R)

Division of Cardiothoracic Surgery, University of Minnesota, Minneapolis, MN, United States.

Andrew Shaffer (A)

Division of Cardiothoracic Surgery, University of Minnesota, Minneapolis, MN, United States.

Cindy Martin (C)

Cardiovascular Division, University of Minnesota, Minneapolis, MN, United States.

Ganesh Raveendran (G)

Cardiovascular Division, University of Minnesota, Minneapolis, MN, United States; Center for Resuscitation Medicine, University of Minnesota, Minneapolis, MN, USA.

Demetris Yannopoulos (D)

Cardiovascular Division, University of Minnesota, Minneapolis, MN, United States; Center for Resuscitation Medicine, University of Minnesota, Minneapolis, MN, USA. Electronic address: yanno001@umn.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH